Yale University
Clinical trials sponsored by Yale University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could ecstasy help people with borderline personality disorder connect better? Results expected Sep 2026 (estimated)
- Text or portal: which gets parents access to Kids' health records faster? Results expected Sep 2026 (estimated)
- Can a mindfulness app help young adults with diabetes? Results expected Sep 2026 (estimated)
- Exercise may ease OCD symptoms in minutes, small trial hopes to prove Results expected Sep 2026 (estimated)
- Live music may soothe Alzheimer's patients and caregivers, yale study hints Results expected Sep 2026 (estimated)
-
Can a diabetes drug boost dialysis efficiency for kidney patients?
Disease control OngoingThis study tests if empagliflozin, a diabetes drug, can reduce sugar absorption during peritoneal dialysis in 30 adults with end-stage kidney disease. Participants will receive either the drug or a placebo in a crossover design, followed by an 8-week open-label phase where everyo…
Phase 4 • Sponsor: Yale University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a diabetes drug curb alcohol cravings after bariatric surgery?
Disease control OngoingThis small pilot study at Yale tests whether semaglutide (a drug used for diabetes and weight loss) can help people who have had bariatric surgery and now struggle with alcohol use disorder. Ten adults will take the drug for three months and be followed for three more months to s…
Phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a common pill protect stroke survivors from another stroke?
Disease control OngoingThis study tests whether adding spironolactone to standard blood pressure treatment helps lower blood pressure more effectively in people who have had a stroke. About 160 adults who had a bleeding or clot-caused stroke are taking spironolactone or continuing their usual care. Res…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can ketamine rewire fear memories to ease PTSD?
Disease control OngoingThis trial tests whether combining ketamine with a week-long exposure therapy can help people with PTSD by enhancing memory reconsolidation and reducing overgeneralized fear. Adults aged 21-70 with PTSD will receive either ketamine or midazolam (a comparison drug) during therapy …
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a new antibody boost lung cancer treatment?
Disease control OngoingThis phase 2 trial is investigating whether an experimental drug called NC318, given alone or combined with the immunotherapy pembrolizumab, can shrink tumors in people with advanced non-small cell lung cancer. The study includes patients whose cancer has progressed despite prior…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Green tea extract may boost fertility in women with fibroids
Disease control OngoingThis study tests whether a low-caffeine green tea extract (EGCG) can shrink uterine fibroids and improve pregnancy and live birth rates in women aged 18-40 who have been trying to conceive for at least six months. Participants take the extract and are monitored for changes in fib…
Phase 3 • Sponsor: Yale University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Breast pump vs. pitocin: a natural way to induce labor?
Disease control OngoingThis study compares using an electric breast pump (or hand stimulation) to standard oxytocin infusion for inducing labor in nearly 1,000 first-time mothers. The goal is to see if nipple stimulation leads to more spontaneous vaginal deliveries and better experiences for moms and b…
Phase 4 • Sponsor: Yale University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can surgery boost survival in metastatic prostate cancer?
Disease control OngoingThis study looks at whether surgically removing the prostate, along with hormone therapy and possibly chemotherapy, can help men whose prostate cancer has already spread. About 190 men with newly diagnosed stage IV prostate cancer will be randomly assigned to get either standard …
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a diabetes drug help heart failure patients shed excess fluid?
Disease control OngoingThis study investigates whether empagliflozin, a drug typically used for diabetes, can help people with worsening heart failure get rid of extra fluid. Researchers will give 60 participants either empagliflozin or a placebo for six weeks, alongside their usual diuretic medication…
Phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Money and mind: can financial coaching ease mental health struggles after incarceration?
Disease control OngoingThis study tests whether combining one-on-one financial coaching with access to safe, affordable banking services can improve both financial health and mental well-being for people recently released from jail or prison. Participants, who self-identify as having mental health or s…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Phone app aims to help heart failure patients in uganda stay healthy
Disease control OngoingThis study tests a new way to help people with heart failure in Uganda manage their condition. It combines a standard care program with a mobile app that tracks symptoms and gives advice. The goal is to see if this approach improves self-care and reduces deaths or hospital stays.…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain implant study tests new epilepsy drug
Disease control OngoingThis early-phase study tested a new drug called BHV-7000 in 5 people with epilepsy who have a brain implant (RNS) that records brain activity. The goal was to see if the drug reduces abnormal electrical activity linked to seizures. Participants took the drug for 4 weeks, and thei…
Phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for hard-to-treat endometrial cancer: targeted drug shows promise in early trial
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 50 people with endometrial cancer that has returned or not responded to platinum chemotherapy. The drug works by delivering chemotherapy directly to cancer cells. The main goal is to see how many patients' tumors shrink or d…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study aims to boost addiction treatment access in communities hardest hit by opioid overdoses
Disease control OngoingThis study looks at ways to help people of color living in areas with high overdose rates start and continue medication-assisted treatment (MAT) for opioid or alcohol use. Researchers will track how many treatment sessions people attend and whether they stick with their medicatio…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common heart pill curb stress drinking?
Disease control PausedThis small pilot study tested whether propranolol, a beta blocker usually used for high blood pressure, can reduce alcohol drinking triggered by stress. Twenty adults with alcohol use disorder were randomly assigned to take propranolol or a placebo for about two weeks, then compl…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a Pre-IVF pill boost baby chances for endometriosis patients?
Disease control OngoingThis Phase 3 trial tests whether taking Elagolix, a hormone-blocking drug, before IVF can increase live birth rates in women with endometriosis. About 97 women will receive either Elagolix or a placebo before their IVF cycle. The goal is to see if this pre-treatment improves the …
Phase 3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug combo aims to boost myeloma treatment
Disease control OngoingThis study tests whether combining two approved drugs, belantamab mafodotin and elotuzumab, is safe and works better than either alone for multiple myeloma. About 24 adults whose cancer has returned or not responded to at least three prior treatments will receive the combination.…
Phase 1/2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New app aims to help people cut down on drinking
Disease control By invitation onlyThis pilot study tests a web-based program called Let's Do Addiction Recovery Together! (LDART) for adults with alcohol use disorder. Participants use the website to set daily goals, watch motivational messages from people in recovery, and find local support groups. The study wil…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New digital app aims to curb cocaine and meth use
Disease control By invitation onlyThis pilot study tests a web-based program called LDART for adults with stimulant use disorder (cocaine or methamphetamine). The program includes daily goal setting, motivational messages from people in recovery, and links to support groups. Researchers want to see if it's feasib…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug combo takes on deadly brain tumor
Disease control OngoingThis early-phase trial tests a combination of two drugs (domvanalimab and zimberelimab) that aim to help the immune system fight glioblastoma, an aggressive brain cancer that has returned after initial treatment. About 46 participants will receive the drugs to check safety and se…
Early phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a weekly shot help obese teens avoid diabetes and fatty liver?
Disease control OngoingThis study tests whether semaglutide (Wegovy), a once-weekly injection, can preserve the pancreas's ability to produce insulin and reduce liver fat in 60 obese youth with prediabetes or early type 2 diabetes and fatty liver disease. Participants receive either semaglutide or a pl…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a Stop-Smoking drug curb heavy drinking in HIV patients?
Disease control OngoingThis pilot study tests whether giving the smoking-cessation drug varenicline to people with HIV who also have alcohol use disorder is practical and safe. Thirty participants will receive the medication along with support from a pharmacist and psychiatrist. The goal is to see if t…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for hard-to-treat ovarian cancer: targeted drug shows promise in early trial
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 20 people with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. The drug works like a guided missile, delivering chemotherapy directly to cancer cells. The mai…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could an arthritis drug curb alcohol cravings?
Disease control OngoingThis early-stage study tests whether a drug called apremilast can help people with Alcohol Use Disorder drink less alcohol. Ten adults will take the medicine and then have their drinking measured in a lab setting. The goal is to see if the drug reduces alcohol consumption, especi…
Phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New program aims to make HIV injections easier for women facing homelessness or food insecurity
Disease control OngoingThis study tests a pharmacist-led program to help women with HIV who also face social challenges like housing or food insecurity. The program supports switching from daily pills to a long-acting injectable medication (cabotegravir/rilpivirine) given every two months. The goal is …
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a Phone-Based program help people with chronic pain cut back on opioids?
Disease control OngoingThis study compares two telemedicine approaches for people with chronic pain and opioid misuse. One program provides standard medication management via remote visits, while the other adds a 12-week self-help program with phone-based coaching. The goal is to see which approach bet…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Cancer immunotherapy side effect study pulled before it began
Disease control CancelledThis study was designed to test whether the drug etrasimod (VELSIPITY) could help reduce the need for steroids in cancer patients who develop diarrhea and colon inflammation from immune checkpoint inhibitors. It planned to enroll about 0 participants with advanced cancer who had …
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New community program aims to tame childhood asthma
Disease control OngoingThis pilot study tests a community-academic partnership to help children with asthma in New Haven. It offers home visits from trained community health workers (Promotoras) and an online tool for doctors to guide asthma care. The goal is to see if this approach is feasible and can…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New combo attack shows promise against tough pancreatic tumors
Disease control OngoingThis study tests a two-step treatment for people with pancreatic cancer that hasn't spread but can't be removed by surgery. First, patients receive a stronger chemotherapy cocktail (modified FOLFIRINOX), followed by precise, high-dose radiation (SBRT). The goal is to see if this …
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a postpartum depression drug curb alcohol cravings in PTSD?
Disease control OngoingThis early study tests whether brexanolone, a drug already approved for postpartum depression, can safely reduce stress-induced alcohol use in 25 adults with both PTSD and alcohol use disorder. Participants receive a continuous 20-hour IV infusion under medical supervision. The m…
Phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Which weight loss surgery works best for teens? study aims to find out
Disease control OngoingThis study follows 26 severely obese teenagers aged 14-19 who chose to have one of three weight loss surgeries: gastric band, sleeve gastrectomy, or gastric bypass. Researchers track weight, body fat, blood sugar, and vitamin levels over time to see which surgery is safest and mo…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 26, 2026 18:19 UTC
-
Could a blood pressure boost save brain cells during a stroke?
Disease control PausedThis pilot study tests whether temporarily raising blood pressure with drugs like phenylephrine or norepinephrine can reduce brain damage in people having a major stroke. About 40 adults with large-vessel blockage strokes will receive the blood pressure boost during standard clot…
Early phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 26, 2026 14:05 UTC
-
AI eye on the heart: new study aims to catch rare disease early
Diagnosis By invitation onlyThis study will test if artificial intelligence (AI) can spot a rare heart condition called ATTR-CM in people with heart failure. Researchers will use AI to analyze electrocardiograms (ECGs) and echocardiograms (Echo) from 150 adults. The AI's findings will be checked against a s…
Sponsor: Yale University • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
AI eyes hidden heart condition: could algorithms catch what doctors miss?
Diagnosis OngoingThis study is testing whether artificial intelligence can detect transthyretin amyloid cardiomyopathy (ATTR-CM), a serious and often underdiagnosed heart condition, earlier than usual. Researchers will use AI algorithms to analyze routine ECGs and heart ultrasounds from up to 1.5…
Sponsor: Yale University • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
AI stethoscope? new study uses smart tech to spot hidden heart danger
Diagnosis By invitation onlyThis study tests whether artificial intelligence (AI) can spot a serious heart valve condition called aortic stenosis using portable, non-invasive devices. Researchers will enroll 410 adults aged 70 and older during routine primary care visits. The goal is to see if AI-powered an…
Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Algorithm aims to spot rare heart disease in medical records
Diagnosis CancelledThis study aimed to test a computer algorithm that uses insurance claims data to identify people with ATTR amyloidosis, a rare disease that affects the heart and nerves. Researchers planned to check how well the algorithm worked by reviewing medical records. However, the study wa…
Early phase 1 • Sponsor: Yale University • Aim: Diagnosis
Last updated Jun 26, 2026 18:38 UTC
-
Can rewards and support keep drug users HIV-Free?
Prevention OngoingThis study tests a 24-week program called CoMPASS that uses rewards (contingency management) and extra support to help people who inject drugs take PrEP consistently for HIV prevention. About 526 participants with opioid use disorder will be enrolled. Those who don't stick with P…
Sponsor: Yale University • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
Can VR keep teens off vapes? yale tests a new approach
Prevention By invitation onlyThis study tests a virtual reality (VR) program designed to help 8th graders avoid e-cigarettes and manage their emotions. Researchers at Yale University will first gather feedback from students and school staff to shape the program, then test whether it is easy to use and accept…
Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
New AR video game aims to curb teen drinking
Prevention By invitation onlyThis study is testing a new augmented reality (AR) video game called "No Time Wasted" to see if it can help teens aged 16-18 learn about alcohol risks and reduce dangerous drinking behaviors. Twenty high school students will play the game using an AR headset and answer surveys ab…
Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Sitz baths tested as pain relief after pelvic surgery
Symptom relief OngoingThis study tests whether taking warm water sitz baths for 10 minutes each night for a week can reduce pain after pelvic organ prolapse repair. 112 women will be randomly assigned to sitz baths or standard care. The main goal is to measure pain intensity one week after surgery usi…
Sponsor: Yale University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Live music may soothe Alzheimer's patients and caregivers, yale study hints
Symptom relief OngoingThis study from Yale University will test whether listening to live music can reduce anxiety and improve brain activity in people with early Alzheimer's disease, dementia, or mild cognitive impairment, along with their caregivers. Sixty pairs (patient and caregiver) will attend b…
Sponsor: Yale University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can mindfulness fix sleep and cut heart risk in black women?
Symptom relief OngoingThis study tests a 6-week mindfulness-based program designed to improve sleep and reduce stress in Black women with insomnia. Researchers will enroll 340 women and track changes in sleep quality, stress levels, and how acceptable and feasible the program is. The goal is to see if…
Sponsor: Yale University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a phone app ease kidney disease stress?
Symptom relief By invitation onlyThis study tests a digital mindfulness app called Calm Health in 26 adults with chronic kidney disease. Participants use the app for 6 weeks while wearing a wrist sensor to track sleep, activity, and heart rate. The goal is to see if the app is easy to use and if it helps reduce …
Sponsor: Yale University • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Maine cancer patients get free groceries and coaching in new study
Symptom relief OngoingThis study is testing whether giving cancer patients in Maine free, medically tailored groceries plus nutrition counseling can improve their diet and well-being. One hundred adults with any stage or type of cancer will be split into three groups: one gets groceries and counseling…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Magnetic pulses to the brain may calm irritability
Symptom relief OngoingThis study tests whether a noninvasive technique called repetitive transcranial magnetic stimulation (rTMS) can reduce irritability by targeting brain circuits involved in frustration. About 20 adults with elevated irritability will receive rTMS while researchers measure brain ac…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New therapy approach aims to keep minority teens in mental health care
Symptom relief By invitation onlyThis study tests a new method called Strategic Treatment Assessment for Youth (STAY) designed to help racial and ethnic minority teens with depression or suicidal thoughts stay in therapy. Researchers will compare STAY to standard care in 140 teens aged 12-18 across three communi…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Nerve zapper offers hope for chronic headache sufferers
Symptom relief By invitation onlyThis study looks at whether a 60-day nerve stimulation device placed near the back of the head can help people with stubborn headaches. Researchers will track pain levels, daily function, and how often participants need emergency care. About 300 adults with various headache types…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Magic mushroom compound tested for OCD in small trial
Symptom relief OngoingThis early-stage study is testing whether repeated doses of psilocybin, the active ingredient in magic mushrooms, can reduce symptoms of obsessive-compulsive disorder (OCD). Twenty-eight adults with moderate-to-severe OCD who have not responded to standard treatments will receive…
Phase 1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
VR headsets aim to ease OCD brain treatment — but study pulled
Symptom relief CancelledThis study planned to see if using virtual reality (VR) before a brain stimulation treatment called TMS could help people with OCD feel more comfortable. It was designed for adults already approved for TMS. However, the study was withdrawn before any participants were enrolled, s…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Talking therapy shows promise for calming outbursts in kids with autism
Symptom relief By invitation onlyThis small pilot study at Yale University is testing a modified form of cognitive-behavioral therapy (CBT) for children with autism and intellectual disability who struggle with irritability, tantrums, and aggression. Up to 6 children aged with an IQ between 55 and 85 will receiv…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy aims to cut pain and opioid use in chronic sufferers
Symptom relief OngoingThis study tests a 24-week program called SC-POWR for 204 adults with opioid use disorder and chronic pain. Participants get medication, therapy, exercise (like Wii Fit and Tai Chi), and stress reduction (relaxation training and acupuncture). The goal is to reduce pain interferen…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple ointment before surgery lead to better scars?
Symptom relief By invitation onlyThis study looks at whether applying a silicone ointment to the skin before head and neck surgery helps wounds heal with less scarring. About 60 adults having non-emergency surgery will take part. Researchers will compare scars using standard rating scales and also track hospital…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New ER tool aims to tame agitation without restraints
Symptom relief PausedThis pilot study tests a tool called ED-TREAT that helps emergency room staff spot and treat agitation early. The goal is to see if the tool is easy to use and can reduce the need for physical restraints. The study involves 26 adults at Yale New Haven Hospital, but enrollment is …
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Pain relief study for IUD insertion pulled before it started
Symptom relief CancelledThis study planned to test whether a small electrical device (TENS) could reduce pain when placing an IUD. It was designed for adults getting a new or replacement IUD. The study was withdrawn before enrolling anyone, so no results are available.
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Beating stress: drum circles tested as anxiety relief for marginalized groups
Symptom relief By invitation onlyThis study looks at whether joining community drum circles and mindfulness programs can help reduce anxiety and depression in Black and other marginalized groups who faced extra stress during COVID-19. About 90 people aged 16 and older will take part. Researchers will measure how…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Music and mindfulness program aims to ease stress in african american communities
Symptom relief By invitation onlyThis study tests whether a virtual, community-based program combining music and mindfulness can help reduce stress, anxiety, and depression in people of African descent. About 300 participants aged 16 and older will take part. The goal is to see if these culturally relevant activ…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Botox study for skin disease pulled before it started
Symptom relief CancelledThis study aimed to see if Botulinum Toxin-A (Botox) could help people with hidradenitis suppurativa, a painful skin condition. It planned to enroll adults with active armpit lesions of similar severity on both sides. However, the study was withdrawn before any participants were …
Phase 4 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Magic mushroom compound shows promise for tough depression
Symptom relief OngoingThis small pilot study tests whether psilocybin, the active ingredient in magic mushrooms, can change brain connections to improve depression. 18 adults with major depression who didn't get better with standard treatments will receive psilocybin. Researchers will measure brain ac…
Phase 1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Can a posture device replace surgery for cubital tunnel syndrome?
Symptom relief PausedThis study tests whether the UpRight Go posture trainer, a wearable device that vibrates when you slouch, can reduce pain, numbness, and weakness in people with cubital tunnel syndrome who haven't had surgery. Researchers at Yale University plan to enroll 40 adults and track symp…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 26, 2026 17:38 UTC
-
Can coaching turn rural clinics into One-Stop shops for addiction and infectious disease care?
Knowledge-focused OngoingResearchers are testing a coaching program to help primary care clinics in rural West Virginia screen and treat opioid use disorder, HIV, and hepatitis C. The program includes group priority-setting, rapid-cycle improvement coaching, and provider training. Twenty clinics will tak…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Rewiring motherhood: brain study targets opioid recovery in new moms
Knowledge-focused PausedThis study looks at whether a 12-session parenting program can change brain activity in mothers recovering from opioid use disorder. Researchers will use EEG to measure brain responses to baby faces and cries before and after the program. The goal is to see if supporting the moth…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Which heart test is best for women? new study aims to find out
Knowledge-focused OngoingThis study looks at 500 women with chest pain to compare two tests used during heart catheterization—FFR and iFR—to see which better predicts future heart problems like heart attacks or strokes. Participants will be followed for 5 years. The goal is to improve how doctors decide …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Heart failure drug flaw revealed in new study
Knowledge-focused OngoingThis study looks at why standard heart failure medications may not fully block a hormone called aldosterone. Researchers will give 20 adults with stable heart failure either a placebo or the drug spironolactone, then measure how the body handles salt and water. The goal is to und…
Phase 4 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
PET scans reveal Cocaine's brain impact
Knowledge-focused OngoingThis study uses PET scans with a special tracer to measure brain synapse density in 80 people—some with cocaine use disorder and some healthy controls. Researchers aim to see if cocaine changes brain connections, especially in areas linked to decision-making and addiction. Partic…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Emergency rooms test new way to protect seniors from dangerous drugs
Knowledge-focused OngoingThis study looks at whether giving doctors feedback about their prescribing habits can reduce the number of potentially harmful medications given to older adults when they leave the emergency department. About 200 clinicians from Yale New Haven Health System are taking part. The …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
Knowledge-focused OngoingThis study aims to measure heart and metabolic risk markers—such as insulin resistance and fat distribution—in young adults aged 18 to 30 with type 1 diabetes and a body mass index under 25. Researchers will track changes over one year using glucose clamps and meal tests. The goa…
Phase 1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Immune cells may hold the key to Parkinson's origins
Knowledge-focused OngoingThis study explores whether the immune system plays a role in starting and driving Parkinson's disease. Researchers will collect blood, spinal fluid, stool, and saliva from people with REM sleep behavior disorder (a strong early sign of Parkinson's), people already diagnosed with…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Can a video help older women decide on breast cancer screening?
Knowledge-focused OngoingThis study tests whether a video or a written guide helps women aged 75 and older make better decisions about breast cancer screening. About 300 women who have had screening before but never had breast cancer will take an online survey. The goal is to see which format reduces con…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Ketamine's brain impact under the scanner: new study targets synaptic loss
Knowledge-focused OngoingThis study uses PET and MRI scans to measure brain cell connections in people with major depression or PTSD. Researchers will give ketamine to see if it can reverse synaptic loss linked to these conditions. The goal is to understand brain changes, not to provide treatment. About …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New study probes emotional impact of Cutting-Edge prostate cancer scans
Knowledge-focused OngoingThis study looks at how a new, more sensitive type of PET scan (PSMA PET) affects the anxiety, decision-making, and quality of life of 350 men with prostate cancer. Participants will fill out surveys about their feelings and experiences over a year. The goal is to understand the …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New study tests whether Family-Focused support helps IPV survivors more
Knowledge-focused OngoingThis study looks at whether a family-centered approach helps caregivers affected by intimate partner violence (IPV) engage more with support services compared to a child-centered approach. About 95 caregivers with children under 5 who were reported to child protective services fo…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
MDMA brain study on PTSD never got off the ground
Knowledge-focused CancelledThis study aimed to see how MDMA changes brain activity in people with PTSD, especially in areas that handle emotions. Researchers planned to give MDMA to a small group and measure brain scans and PTSD symptoms. However, the study was withdrawn before any participants were enroll…
Phase 1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can artificial intelligence predict heart valve disease progression?
Knowledge-focused By invitation onlyThis study will enroll 210 adults aged 65 and older with early aortic stenosis (a heart valve narrowing) to see if an artificial intelligence tool can better predict how fast the disease worsens. Participants will have standard echocardiograms, and researchers will compare the AI…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Study tests how a drink and a puff impact your driving
Knowledge-focused OngoingThis study looks at how small amounts of alcohol and THC (the active part of cannabis) affect driving in a simulator. Forty adults aged 21 to 55 who have used both substances before will take part. The goal is to understand how these drugs change driving performance and thinking,…
Phase 1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Study reveals how booze and weed impair your driving
Knowledge-focused OngoingThis study looks at how alcohol and cannabis, alone or together, affect driving ability and thinking. About 40 occasional cannabis users who also drink alcohol will use a driving simulator after taking controlled doses. The goal is to understand the risks of driving under the inf…
Phase 1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Yale scans brains of synthetic pot users to uncover addiction clues
Knowledge-focused OngoingThis observational study at Yale uses PET brain scans to measure CB1 receptor availability in 15 people who currently use synthetic cannabinoids. Researchers want to see if these receptors are lower in users and how that relates to thinking skills and brain rhythms during withdra…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Study reveals how booze and weed mess with your driving
Knowledge-focused OngoingThis study looks at how alcohol and cannabis, alone or together, affect driving and thinking. About 40 occasional users aged 21–55 will take part. They will inhale low-dose THC (like a quarter of a joint) and drink alcohol, then test their driving on a simulator and complete ques…
Phase 1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
THC study aims to unravel Cannabis's impact on memory
Knowledge-focused OngoingThis study at Yale University looks at how THC, the active ingredient in cannabis, affects short-term and long-term memory. Researchers will give 80 adults who have used cannabis before either a low dose of THC or a placebo and then test their memory. The goal is to better unders…
Phase 1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Study reveals how booze and weed impair your driving
Knowledge-focused OngoingThis study looks at how alcohol and cannabis, alone or together, affect driving ability and thinking. About 40 adults aged 21–55 who have used both substances before will take part. They will complete simulated driving tests and questionnaires after receiving the substances. The …
Phase 1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple screening help adult students overcome depression and stay in school?
Knowledge-focused By invitation onlyThis study looks at whether a program called SBIRT (Screening, Brief Intervention, and Referral to Treatment) can help adult education students with behavioral health issues like depression, anxiety, and substance use. About 340 students and staff from New Haven Adult Education w…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scientists hunt for hidden genes behind aortic aneurysms
Knowledge-focused OngoingThis study aims to uncover the genetic roots of aortic aneurysms and valve disease by analyzing tissue and blood samples from 3,000 participants. Researchers will look for new disease-causing genes and factors that affect disease severity. The goal is to build a biorepository to …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Drum circles and meditation: a new way to beat stress?
Knowledge-focused By invitation onlyThis study explores whether listening to recordings of communal drumming, combined with mindfulness, can reduce stress and improve mental health in People of African Descent. Researchers will measure feelings of connection and synchrony in 30 adults. The goal is to see if cultura…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Brain zaps may boost social skills in autism
Knowledge-focused OngoingThis study tests whether a non-invasive brain stimulation technique called repetitive Transcranial Magnetic Stimulation (rTMS) can change how adults with autism process social information. Researchers will measure brain responses with EEG and eye-tracking before and after stimula…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Mystery chest pain: study digs deeper to find hidden heart problems
Knowledge-focused OngoingThis study involves 500 people who have chest pain or other signs of heart trouble, but whose main heart arteries are not blocked. Researchers use special tools during a heart catheterization to measure tiny blood vessel function and look for hidden causes like microvascular dise…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Blood test may spot tiny heart blockages in transplant patients
Knowledge-focused CancelledThis study aimed to see if a simple blood test could find blockages in the small blood vessels of the heart in people who have had a heart transplant. Participants would have had blood draws every three months for a year, and their medical records would have been reviewed for thr…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Cannabis study aims to unlock HIV immune secrets
Knowledge-focused OngoingThis study looks at how cannabis (specifically the drug Dronabinol) changes the immune system and genes in people with HIV. Researchers will take blood samples before and after giving Dronabinol to 160 participants. The goal is to understand these changes better, which could help…
Phase 1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Massive study aims to predict and understand seizures after stroke
Knowledge-focused By invitation onlyThis study gathers information from 8,000 stroke patients worldwide to learn more about seizures that happen after a stroke. Researchers will analyze the data to see how well patients recover and to create a tool that can predict who might develop epilepsy. The goal is to improve…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New study aims to set better standards for treating severe leg artery disease
Knowledge-focused OngoingThis study is collecting information from 458 people with critical limb-threatening ischemia, a severe form of peripheral artery disease that can lead to amputation. The goal is to learn how different treatments affect patients' daily lives and health outcomes. Researchers hope t…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Writing away burnout? study for PA students pulled before it began
Knowledge-focused CancelledThis study was designed to test whether a guided reflective writing program could reduce burnout in physician assistant students at Yale. The plan was to have students attend three 75-minute writing workshops and measure changes in burnout using a standard questionnaire. However,…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:41 UTC